Landscapes / Companies
Inhibikase Therapeutics not checked
FollowEvery new trial, moved date and filing, and a Monday email
Drugs
1
in active trials · 2 in all
Trials
2 active
4 since 2021
Drugs1
| Drug | How it works | Partner | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
— |
Phase 3 | Jun 2029Phase 3 trial completes | |||
| Next date | Jun 2029 · Phase 3 trial completes | ||||
| Also tested for | Pulmonary Arterial Hypertension, Pulmonary Arterial Hypertension (PAH) | ||||
| Open drug page | |||||
About
- No active trial
- IkT-001Pro
- SEC filings
- None: it does not file with the US SEC
- Sources
- ClinicalTrials.gov updated 19 Nov 2026 Industry-sponsored drug trials since 2021